Similar to hereditary OC, most current evidence-based strategies for managing patients with known inherited risks of breast cancer (e.g. germline BRCA1/2 variants) rely on prophylactic surgeries such as bilateral mastectomies [15]. This evidence concerns the gene BRCA1 and breast carcinoma.